| Literature DB >> 35052931 |
Nicole Jacqueline Kalnins1, Catriona Croton2, Mark Haworth1, Justine Gibson1, Sarah Leonie Purcell1, Allison Jean Stewart1.
Abstract
Although dog-to-dog bite wounds (DBW) are a common presentation to veterinary clinics, antimicrobial prescribing habits of Australian clinics have not been reported. This study determined the frequency and results of DBW cultures; antimicrobial selection; and importance class of antimicrobials prescribed relative to wound severity, geographic location, or year. A systematic sample of 72,507 patient records was retrieved from the VetCompass Australia database. Records for 1713 dog bite events involving 1655 dogs were reviewed for presenting signs, results of culture and susceptibility testing (C&S), antimicrobial treatment, geographical location, and outcome. A crossed random effects multivariable logistic regression model was used to determine if antimicrobial importance was associated with wound severity, year, and location, and to assess the differences in antimicrobial prescription between geographical locations, clinics, and veterinarians. Antimicrobials were prescribed in 86.1% of DBW. Amoxicillin-clavulanic acid was prescribed in 70% (1202/1713) with underdosing in 15.8% (191/1202). High-importance antimicrobial use was associated with wound severity (p < 0.001), year category (p = 0.007), and surgery (p = 0.03). C&S testing was recorded as having been performed in only one case. Differences in individual veterinarian prescribing habits were stronger than the clinic culture, suggesting that education utilizing clinic-wide antimicrobial guidelines may aid in improving antimicrobial stewardship.Entities:
Keywords: VetCompass Australia; antimicrobial stewardship; antimicrobial susceptibility; bacteriology; bite wounds; canine
Year: 2022 PMID: 35052931 PMCID: PMC8773322 DOI: 10.3390/antibiotics11010055
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Comparison of baseline patient characteristics of initial versus analytic (removal of dogs that did not receive antimicrobials and incomplete records) datasets for dogs presenting with dog-to-dog bite wounds from 1998 to 2018.
| Full Dataset | Analytic Dataset | |||
|---|---|---|---|---|
|
| 4.6 | 4.7 | 0.62 | 1.0 |
|
| 0.03 * | 0.33 | ||
| Male | 901 (54.4%) | 746 (53.1%) | ||
| Female | 754 (45.6%) | 659 (46.9%) | ||
|
| 0.58 | 1.0 | ||
| Desexed | 1125 (68.0%) | 972 (69.2%) | ||
| Entire | 530 (32.0%) | 433 (30.8%) | ||
|
| 19.0 | 19.0 | 0.18 | 1.0 |
|
| <0.001 * | <0.001 * | ||
| Grade 1 | 219 (12.8%) | 128 (9.1%) | ||
| Grade 2 | 223 (13.0%) | 179 (12.7%) | ||
| Grade 3 | 457 (26.7%) | 401 (28.5%) | ||
| Grade 4 | 799 (46.6%) | 689 (49.0%) | ||
| Grade 5 | 15 (0.9%) | 8 (0.6%) | ||
|
| 0.004 * | 0.052 | ||
| NSW | 382 (22.3%) | 337 (24.0%) | ||
| QLD | 993 (58.0%) | 794 (56.5%) | ||
| VIC | 224 (13.1%) | 177 (12.6%) | ||
| ACT | 49 (2.9%) | 39 (2.8%) | ||
| SA | 62 (3.6%) | 55 (3.9%) | ||
| WA | 3 (0.2%) | 3 (0.2%) | ||
|
| <0.001 * | <0.001 * | ||
| 1998–2004 | 321 (18.7%) | 221 (15.7%) | ||
| 2005–2009 | 501 (29.3%) | 395 (28.1%) | ||
| 2010–2014 | 518 (30.2%) | 459 (32.7%) | ||
| 2015–2018 | 373 (21.8%) | 330 (23.5%) | ||
|
| <0.001 * | <0.001 * | ||
| No antimicrobials | 158 (9.2%) | 0 (0%) | ||
| Monotherapy | 1296 (75.7%) | 1167 (83.1%) | ||
| Polytherapy | 259 (15.1%) | 238 (16.9%) | ||
|
| <0.001 * | <0.001 * | ||
| No antimicrobials | 158 (9.2%) | 0 (0%) | ||
| Low | 126 (7.4%) | 108 (7.7%) | ||
| Medium | 1360 (79.4%) | 1231 (87.6%) | ||
| High | 69 (4.0%) | 66 (4.7%) | ||
|
| 1 (0.1%) | 1 (0.1%) | 1.0 | 1.0 |
|
| 0.94 | 1.0 | ||
| <1 h | 68 (4.0%) | 53 (3.8%) | ||
| 1–8 h | 187 (10.9%) | 154 (11.0%) | ||
| 8–24 h | 234 (13.7%) | 193 (13.7%) | ||
| >24 h | 622 (36.3%) | 507 (36.1%) | ||
| Unknown | 602 (35.1%) | 498 (35.4%) | ||
|
| 0.65 | 1.0 | ||
| Spring | 414 (24.2%) | 335 (23.8%) | ||
| Summer | 409 (23.9%) | 345 (24.6%) | ||
| Autumn | 404 (23.6%) | 326 (23.2%) | ||
| Winter | 486 (28.4%) | 399 (28.4%) | ||
|
| 0 | 0 | 0.18 | 1.0 |
Uncorrected p value; p value corrected for multiple comparisons using Bonferroni method; By unique consultation. IQR—interquartile range; * Significant at the 0.05 level; Queensland (QLD), New South Wales (NSW), Victoria (VIC), South Australia (SA), Australian Capital Territory (ACT), and Western Australia (WA).
Figure 1Sample proportions of antimicrobials by the number of oral and parenteral antimicrobials prescribed (omitted one dog with four antimicrobials dispensed).
Number of events prescribed antimicrobials and route of administration in dogs which presented for treatment of dog-to-dog bite wounds from 1998 to 2018.
| Antimicrobial | Number of Events | % |
|---|---|---|
| Amoxicillin-clavulanic acid parenteral (SQ) | 578 | 33.7 |
| Amoxicillin-clavulanic acid oral | 1117 | 65.2 |
| Cephalosporin (1st generation) parenteral (IV) | 39 | 2.2 |
| Cephalosporin (1st generation) oral | 185 | 10.7 |
| Cephalosporin (3rd generation) parenteral (SQ) | 27 | 1.5 |
| Fluoroquinolone parenteral (SQ, IV) | 36 | 2.1 |
| Fluoroquinolone oral | 27 | 1.5 |
| Metronidazole parenteral (IV) | 8 | 0.4 |
| Metronidazole oral | 80 | 4.6 |
| Penicillin narrow spectrum parenteral | 25 | 1.4 |
| Penicillin extended spectrum parenteral (SQ, IV) | 38 | 2.2 |
| Penicillin extended spectrum oral * | 44 | 2.5 |
| Sulphonamide parenteral (SQ) | 2 | 0.1 |
| Trimethoprim Sulphonamide oral | 5 | 0.2 |
| Tetracycline oral | 7 | 0.4 |
| Lincosamide oral | 24 | 1.4 |
| Topical antimicrobial * | 147 | 8.5 |
* Neomycin. Subcutaneous (SQ), intravenous (IV).
Antimicrobial dosage, frequency, and duration of administration prescribed to treat dog-to-dog bite wounds in 1713 dogs, which presented for treatment between 1998 and 2018.
| Dosage (mg/kg) | Frequency (Dose per Day) | Duration (Days) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Median | Minimum | Maximum | Median | Minimum | Maximum | Median | Minimum | Maximum | |
| Amoxicillin-clavulanic acid parenteral | 9.1 | 2.8 | 43.8 | 1 | 1 | 2 | 1 | 1 | 5 |
| Amoxicillin-clavulanic acid oral | 14.1 | 1.2 | 48.1 | 2 | 2 | 3 | 7 | 2 | 21 |
| 1st generation cephalosporin parenteral | 14.5 | 2.4 | 25 | 4 | 1 | 5 | 1 | 1 | 5 |
| 1st generation cephalosporin oral | 18.7 | 3.5 | 36.3 | 2 | 1 | 3 | 7 | 5 | 21 |
| 3rd generation cephalosporin parenteral | 8 | 0.1 | 11.9 | 1 | 1 | 1 | 21 | 21 | 21 |
| Fluoroquinolone parenteral | 5 | 0.1 | 23.7 | 1 | 1 | 1 | 1 | 1 | 1 |
| Fluoroquinolone oral | 5.8 | 2.2 | 12.5 | 1 | 1 | 2 | 7 | 2 | 14 |
| Metronidazole parenteral | 10 | 5 | 19.2 | 1.5 | 1 | 2 | 1 | 1 | 2 |
| Metronidazole oral | 16.35 | 6.9 | 34.9 | 2 | 1 | 2 | 7 | 3 | 14 |
| Penicillin narrow spectrum parenteral | 16.7 | 8.6 | 38.6 | 1 | 1 | 1 | 1 | 1 | 5 |
| Penicillin extended spectrum parenteral | 13.3 | 4.4 | 26.8 | 1 | 1 | 4 | 2 | 1 | 7 |
| Penicillin extended spectrum oral | 11 | 5.3 | 24.5 | 2 | 1 | 3 | 6 | 4 | 14 |
| Sulphonamide parenteral | 12.9 | 11.4 | 14.4 | 1 | 1 | 1 | 1 | 1 | 1 |
| Sulphonamide oral | 13.6 | 2.4 | 29.8 | 2 | 2 | 2 | 6 | 5 | 10 |
| Tetracycline oral | 3.95 | 2.5 | 50 | 2 | 1 | 2 | 10 | 7 | 21 |
| Lincosamide oral | 6.1 | 2.3 | 13.4 | 2 | 2 | 2 | 7 | 4 | 14 |
Antimicrobial dosage [10,11] for each class of antimicrobial importance prescribed to dogs that presented for treatment of dog-to-dog bite wounds from 1998 to 2018.
| Antimicrobial Classification | Antimicrobial Dosage | Number of DBW Events | % |
|---|---|---|---|
| Low | Low | 37 | 29.3 |
| Appropriate | 12 | 9.6 | |
| High | 2 | 1.6 | |
| Not enough data | 75 | 59.5 | |
| Medium | Low | 400 | 29.4 |
| Appropriate | 546 | 40.1 | |
| High | 323 | 23.7 | |
| Not enough data | 91 | 6.7 | |
| High | Low | 30 | 43.4 |
| Appropriate | 25 | 36.2 | |
| High | 14 | 20.2 | |
| Not enough data | 0 | 0 |
Figure 2Antimicrobial importance prescribed per year category for the treatment of dogs presenting with dog-to-dog bite wounds from 1998–2004 to 2015–2018.
Figure 3Antimicrobial importance prescribed per state (excluding WA due to low numbers) for the treatment of dogs presenting with dog-to-dog bite wounds from 1998 to 2018.
Figure 4Antimicrobial importance class prescribed versus wound severity grade for 1713 dog-to-dog bite events presenting for treatment between 1998 to 2018.
Crossed random effects multivariable ordinal multivariable logistic regression results for prescribing an antimicrobial of higher importance for dog-to-dog bite wounds presenting for treatment from 1998 to 2018 (n = 1405 consults, 1375 dogs, 610 veterinarians, 120 clinics).
| Odds Ratio | 95% Confidence Interval | ||
|---|---|---|---|
|
| 1.75 | 1.43–2.13 | <0.001 * |
| Baseline | 0.007 * | ||
| 2005–2009 | 1.70 | 0.93, 3.11 | 0.09 |
| 2010–2014 | 2.37 | 1.26, 4.45 | 0.007 * |
| 2015–2018 | 3.23 | 1.63, 6.42 | 0.001 * |
|
| 0.027 * | ||
| No surgery performed or recommended | Baseline | ||
| Surgery performed | 1.75 | 1.11, 2.78 | 0.017 |
| Surgery recommended, not performed | 0.57 | 0.19, 1.76 | 0.33 |
| Cutpoint 1 | −0.92 | −1.59, −0.24 | |
| Cutpoint 2 | 6.72 | 5.60, 7.84 | |
| Clinic variance | 0.54 | 0.21, 1.38 | <0.001 *a |
| Veterinarian variance | 2.14 | 0.95, 4.82 | <0.001 *a |
* Significant at the 0.05 level. The p values for the individual levels of the categorical variables compared to the baseline are given, with a bolded p value for all levels of that categorical variable combined. a Likelihood ratio test of variance component.
Figure 5Flow diagram of the methodology of data collection for analysis of patients presenting for dog-to-dog bite wounds in the VetCompass Australia database from 1998-2018.
Antimicrobial classification adapted from the Australian Strategic and Technical Advisory Group on Antimicrobial Resistance relevant to the treatment of DBW [34].
| Antimicrobial Importance | Antimicrobial |
|---|---|
| Low | penicillin |
| sulphonamides | |
| tetracyclines | |
| Medium | amoxicillin-clavulanic acid |
| 1st & 2nd generation cephalosporins | |
| lincosamides | |
| metronidazole | |
| piperacillin/tazobactam | |
| High | 3rd generation cephalosporins |
| fluoroquinolones |